International Consensus Statement on Postoperative Anemia Management Recommends Noninvasive Hemoglobin Measurement Including Masimo SpHb®
Masimo Corporation (MASI)
Last masimo corporation earnings: 4/28 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
masimo.com/about-masimo/investors
Company Research
Source: Business Wire
NEUCHATEL, Switzerland--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that a new consensus statement on postoperative anemia management was published in Anaesthesia by an international panel of clinicians specializing in patient blood management, which includes clear guidance on the use and benefits of noninvasive hemoglobin measurement.1 The statement, which discusses both spot-check and continuous measurement, references the Masimo Rad-67™ Pulse CO-Oximeter®, a spot-check device that measures noninvasive hemoglobin using Masimo SpHb®, as the example of noninvasive measurement. This press release features multimedia. View the full release here:https://www.businesswire.com/news/home/20181111005053/en/ Masimo Rad-67™ with SpHb® (Photo: Business Wire) The statement notes in part that “The use of non-invasive continuous haemoglobin monitoring devices instead of phlebotomy may reduce blood loss, pai
Show less
Read more
Impact Snapshot
Event Time:
MASI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MASI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MASI alerts
High impacting Masimo Corporation news events
Weekly update
A roundup of the hottest topics
MASI
News
- Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Reasons Why You Should Retain Masimo (MASI) Stock for Now [Yahoo! Finance]Yahoo! Finance
- Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in ChileBusiness Wire
- Masimo Co. (NASDAQ: MASI) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $170.00 price target on the stock, up previously from $148.00.MarketBeat
- Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False ClaimsBusiness Wire
MASI
Earnings
- 2/27/24 - Beat
MASI
Sec Filings
- 4/2/24 - Form DEFA14A
- 4/1/24 - Form DEFA14A
- 3/27/24 - Form SC
- MASI's page on the SEC website